Inpatient COVID-19 mortality has reduced over time: Results from an observational cohort.
Autorzy :
Bechman K; Centre for Rheumatic Diseases, King's College London, London, United Kingdom. Yates M; Centre for Rheumatic Diseases, King's College London, London, United Kingdom. Mann K; Centre for Rheumatic Diseases, King's College London, London, United Kingdom. Nagra D; Centre for Rheumatic Diseases, King's College London, London, United Kingdom. Smith LJ; King's College Hospital NHS Foundation Trust, London, United Kingdom. Rutherford AI; King's College Hospital NHS Foundation Trust, London, United Kingdom. Patel A; King's College Hospital NHS Foundation Trust, London, United Kingdom. Periselneris J; King's College Hospital NHS Foundation Trust, London, United Kingdom. Walder D; King's College Hospital NHS Foundation Trust, London, United Kingdom. Dobson RJB; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.; NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, United Kingdom.; Health Data Research UK London, University College London, London, United Kingdom. Kraljevic Z; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom. Teo JHT; King's College Hospital NHS Foundation Trust, London, United Kingdom.; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom. Bernal W; King's College Hospital NHS Foundation Trust, London, United Kingdom.; School of Immunology and Microbial Sciences, King's College London, London, United Kingdom. Barker R; Centre for Rheumatic Diseases, King's College London, London, United Kingdom. GallowayJB; Centre for Rheumatic Diseases, King's College London, London, United Kingdom. Norton S; Centre for Rheumatic Diseases, King's College London, London, United Kingdom.; Psychology Department, King's College London, London, United Kingdom.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2022 Jan 13; Vol. 17 (1), pp. e0261142. Date of Electronic Publication: 2022 Jan 13 (Print Publication: 2022).
Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort study.
Autorzy :
Mahil SK; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, UK.; St John's Institute of Dermatology, Faculty of Life Sciences and Medicine, King's College London, London, UK. Bechman K; Centre for Rheumatic Diseases, King's College London, London, UK. Raharja A; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, UK. Domingo-Vila C; Department of Immunobiology, Faculty of Life Sciences and Medicine, King's College London, London, UK. Baudry D; St John's Institute of Dermatology, Faculty of Life Sciences and Medicine, King's College London, London, UK. Brown MA; Centre for Rheumatic Diseases, King's College London, London, UK. Cope AP; Centre for Rheumatic Diseases, King's College London, London, UK. Dasandi T; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, UK. Graham C; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK. Khan H; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK. Lechmere T; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK. Malim MH; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK. Meynell F; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, UK. Pollock E; Department of Immunobiology, Faculty of Life Sciences and Medicine, King's College London, London, UK. Sychowska K; Department of Immunobiology, Faculty of Life Sciences and Medicine, King's College London, London, UK. Barker JN; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, UK.; St John's Institute of Dermatology, Faculty of Life Sciences and Medicine, King's College London, London, UK. Norton S; Psychology Department, Institute for Psychiatry Psychology and Neuroscience, King's College London, London, UK. GallowayJB; Centre for Rheumatic Diseases, King's College London, London, UK. Doores KJ; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK. Tree T; Department of Immunobiology, Faculty of Life Sciences and Medicine, King's College London, London, UK. Smith CH; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, UK.; St John's Institute of Dermatology, Faculty of Life Sciences and Medicine, King's College London, London, UK.
Pokaż więcej
Źródło :
The Lancet. Rheumatology [Lancet Rheumatol] 2022 Jan; Vol. 4 (1), pp. e42-e52. Date of Electronic Publication: 2021 Nov 09.
Adas MA; Centre of Rheumatic diseases, School of Immunology & Microbial Sciences, King's College London, London, UK.; Department of Physiology, Faculty of Medicine, University of Jeddah, Jeddah, Saudi Arabia. Alveyn E; Centre of Rheumatic diseases, School of Immunology & Microbial Sciences, King's College London, London, UK. Cook E; Centre of Rheumatic diseases, School of Immunology & Microbial Sciences, King's College London, London, UK. Dey M; Institute of Life Course & Medical Sciences, University of Liverpool, Liverpool, UK.; Department of Rheumatology, Countess of Chester Hospital Nhs Foundation Trust, Chester, UK. GallowayJB; Centre of Rheumatic diseases, School of Immunology & Microbial Sciences, King's College London, London, UK. Bechman K; Centre of Rheumatic diseases, School of Immunology & Microbial Sciences, King's College London, London, UK.
Improving outcomes for patients hospitalized with gout: a systematic review.
Autorzy :
Russell MD; Centre for Rheumatic Diseases, King's College London, London, UK. Clarke BD; Centre for Rheumatic Diseases, King's College London, London, UK. Roddy E; School of Medicine, Keele University, Keele, UK.; Haywood Academic Rheumatology Centre, Midland Partnership NHS Foundation Trust, Stoke-on-Trent, UK. GallowayJB; Centre for Rheumatic Diseases, King's College London, London, UK.
Systematic Review and Metaanalysis of the Reproducibility of Patient Self-reported Joint Counts in Rheumatoid Arthritis.
Autorzy :
Rampes S; S. Rampes, MA, V. Patel, MSc, Faculty of Life Sciences & Medicine, King's College London, London. Patel V; S. Rampes, MA, V. Patel, MSc, Faculty of Life Sciences & Medicine, King's College London, London. Bosworth A; A. Bosworth, C. Jacklin, National Rheumatoid Arthritis Society, Berkshire. Jacklin C; A. Bosworth, C. Jacklin, National Rheumatoid Arthritis Society, Berkshire. Nagra D; D. Nagra, MD, M. Yates, PhD, S. Norton, PhD, J.B. Galloway, PhD, Centre for Rheumatic Diseases, King's College London, London, UK. Yates M; D. Nagra, MD, M. Yates, PhD, S. Norton, PhD, J.B. Galloway, PhD, Centre for Rheumatic Diseases, King's College London, London, UK. Norton S; D. Nagra, MD, M. Yates, PhD, S. Norton, PhD, J.B. Galloway, PhD, Centre for Rheumatic Diseases, King's College London, London, UK. GallowayJB; D. Nagra, MD, M. Yates, PhD, S. Norton, PhD, J.B. Galloway, PhD, Centre for Rheumatic Diseases, King's College London, London, UK.
Pokaż więcej
Źródło :
The Journal of rheumatology [J Rheumatol] 2021 Dec; Vol. 48 (12), pp. 1784-1792. Date of Electronic Publication: 2021 May 15.
Response to letter to editor (AR-21-1598) - Nonserious infections, Respiratory virus.
Autorzy :
Bechman K; Centre for Rheumatic Diseases, School of Immunology and Microbial Sciences, Kings College London, United Kingdom. GallowayJB; Centre for Rheumatic Diseases, School of Immunology and Microbial Sciences, Kings College London, United Kingdom.
Corrigendum to: Diagnostic delay is common for patients with axial spondyloarthritis: results from the National Early Inflammatory Arthritis Audit.
Autorzy :
Russell MD; Centre for Rheumatic Diseases, King's College London, London. Coath F; Rheumatology Department, Norfolk and Norwich University Hospital, Norwich. Yates M; Centre for Rheumatic Diseases, King's College London, London. Bechman K; Centre for Rheumatic Diseases, King's College London, London. Norton S; Centre for Rheumatic Diseases, King's College London, London. GallowayJB; Centre for Rheumatic Diseases, King's College London, London. Ledingham J; Rheumatology Department, Portsmouth Hospitals University NHS Trust, Portsmouth. Sengupta R; Department of Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath, UK. Gaffney K; Rheumatology Department, Norfolk and Norwich University Hospital, Norwich.
A systematic review and network meta-analysis of the safety of early interventional treatments in rheumatoid arthritis.
Autorzy :
Adas MA; Centre for Rheumatic Diseases, King's College London, London, UK. Allen VB; Centre for Rheumatic Diseases, King's College London, London, UK. Yates M; Centre for Rheumatic Diseases, King's College London, London, UK. Bechman K; Centre for Rheumatic Diseases, King's College London, London, UK. Clarke BD; Centre for Rheumatic Diseases, King's College London, London, UK. Russell MD; Centre for Rheumatic Diseases, King's College London, London, UK. Rutherford AI; Centre for Rheumatic Diseases, King's College London, London, UK. Cope AP; Centre for Rheumatic Diseases, King's College London, London, UK. Norton S; Centre for Rheumatic Diseases, King's College London, London, UK. GallowayJB; Centre for Rheumatic Diseases, King's College London, London, UK.
Disease activity and its predictors in early inflammatory arthritis: findings from a national cohort.
Autorzy :
Yates M; Centre for Rheumatic Diseases, King's College London. Ledingham JM; Department Rheumatology, Queen Alexandra Hospital, Portsmouth, UK. Hatcher PA; British Society for Rheumatology, NEIAA Patient Panel. Adas M; Centre for Rheumatic Diseases, King's College London. Hewitt S; Healthcare Quality Improvement Partnership. Bartlett-Pestell S; Healthcare Quality Improvement Partnership. Rampes S; King's College London, Faculty of Life Sciences and Medicine. Norton S; Centre for Rheumatic Diseases, King's College London. GallowayJB; Centre for Rheumatic Diseases, King's College London.; Department of Rheumatology, King's College London, UK.
Nonserious Infections in Patients With Rheumatoid Arthritis: Results From the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
Autorzy :
Bechman K; Kings College London, London, UK. Halai K; Kings College London, London, UK. Yates M; Kings College London, London, UK. Norton S; Kings College London, London, UK. Cope AP; Kings College London, London, UK. Hyrich KL; Manchester Academic Health Sciences Centre, University of Manchester, NIHR Manchester Biomedical Research Centre, and Manchester University NHS Foundation Trust, Manchester, UK. GallowayJB; Kings College London, London, UK.
Describing the burden of the COVID-19 pandemic in people with psoriasis: findings from a global cross-sectional study.
Autorzy :
Mahil SK; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK. Yates M; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.; Centre for Rheumatic Diseases, King's College London, London, UK. Yiu ZZN; Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK. Langan SM; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.; Faculty of Epidemiology, and Population Health, London School of Hygiene and Tropical Medicine, London, UK. Tsakok T; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK. Dand N; Department of Medical and Molecular Genetics, School of Basic and Medical Biosciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.; Health Data Research UK, London, UK. Mason KJ; Centre for Rheumatic Diseases, King's College London, London, UK.; School of Medicine, Keele University, Keele, UK. McAteer H; The Psoriasis Association, Northampton, UK. Meynell F; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK. Coker B; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK. Vincent A; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK. Urmston D; The Psoriasis Association, Northampton, UK. Vesty A; The Psoriasis Association, Northampton, UK. Kelly J; Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK. Lancelot C; International Federation of Psoriasis Associations (IFPA), Bromma, Sweden. Moorhead L; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK. Bachelez H; Department of Dermatology, AP-HP Hôpital Saint-Louis, Paris, France.; INSERM U1163, Imagine Institute for Human Genetic Diseases, Université de Paris, Paris, France. Capon F; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.; Department of Medical and Molecular Genetics, School of Basic and Medical Biosciences, Faculty of Life Sciences and Medicine, King's College London, London, UK. Contreras CR; Catedra de Dermatologia, Hospital de Clinicas, Facultad de Ciencias Medicas, Universidad Nacional de Asuncion, San Lorenzo, Paraguay. De La Cruz C; Clinica Dermacross, Santiago, Chile. Di Meglio P; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.; St John's Institute of Dermatology, School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, King's College London, London, UK. Gisondi P; Section of Dermatology and Venereology, University of Verona, Verona, Italy. Jullien D; Department of Dermatology, Edouard Herriot Hospital, Hospices Civils de Lyon, University of Lyon, Lyon, France.; Groupe de Recherche sur le Psoriasis (GrPso) de la Société Française de Dermatologie, Paris, France. Lambert J; Department of Dermatology, Ghent University, Ghent, Belgium. Naldi L; Centro Studi GISED, Bergamo, Italy. Norton S; Psychology Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK. Puig L; Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain. Spuls P; Department of Dermatology, Amsterdam Public Health/Infection and Immunology, Amsterdam University Medical Centers, Location AMC, Amsterdam, The Netherlands. Torres T; Department of Dermatology, Centro Hospitalar do Porto, Porto, Portugal. Warren RB; Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK. Waweru H; International Federation of Psoriasis Associations (IFPA), Bromma, Sweden. Weinman J; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK. Brown MA; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.; Centre for Rheumatic Diseases, King's College London, London, UK. GallowayJB; Centre for Rheumatic Diseases, King's College London, London, UK.; Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK. Griffiths CM; Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK. Barker JN; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.; St John's Institute of Dermatology, School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, King's College London, London, UK. Smith CH; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study.
Autorzy :
Mahil SK; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, King's College London, London, UK. Bechman K; Centre for Rheumatic Diseases, King's College London, London, UK. Raharja A; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, King's College London, London, UK. Domingo-Vila C; Department of Immunobiology, Faculty of Life Sciences & Medicine, King's College London, London, UK. Baudry D; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, King's College London, London, UK. Brown MA; Centre for Rheumatic Diseases, King's College London, London, UK. Cope AP; Centre for Rheumatic Diseases, King's College London, London, UK. Dasandi T; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, King's College London, London, UK. Graham C; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK. Lechmere T; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK. Malim MH; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK. Meynell F; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, King's College London, London, UK. Pollock E; Department of Immunobiology, Faculty of Life Sciences & Medicine, King's College London, London, UK. Seow J; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK. Sychowska K; Department of Immunobiology, Faculty of Life Sciences & Medicine, King's College London, London, UK. Barker JN; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, King's College London, London, UK. Norton S; Psychology Department, Institute for Psychiatry Psychology and Neuroscience, King's College London, London, UK. GallowayJB; Centre for Rheumatic Diseases, King's College London, London, UK. Doores KJ; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK. Tree TIM; Department of Immunobiology, Faculty of Life Sciences & Medicine, King's College London, London, UK. Smith CH; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, King's College London, London, UK.
Pokaż więcej
Źródło :
The Lancet. Rheumatology [Lancet Rheumatol] 2021 Sep; Vol. 3 (9), pp. e627-e637. Date of Electronic Publication: 2021 Jul 08.
The COVID-19 Vaccine Landscape: What a Rheumatologist Needs to Know.
Autorzy :
Bechman K; K. Bechman, PhD, M. Yates, PhD, J.B. Galloway, PhD, Centre for Rheumatic Diseases, Kings College London, London, UK; . Dey M; M. Dey, MB BChir., Institute of Life Course and Medical Sciences, University of Liverpool, and Rheumatology, Aintree University Hospital, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK. Yates M; K. Bechman, PhD, M. Yates, PhD, J.B. Galloway, PhD, Centre for Rheumatic Diseases, Kings College London, London, UK. Bukhari M; M. Bukhari, PhD, Rheumatology, Royal Lancaster Infirmary, Lancaster, UK. Winthrop K; K. Winthrop, MD, MPH, Division of Infectious Diseases, Oregon Health & Science University, Portland, Oregon, USA. GallowayJB; K. Bechman, PhD, M. Yates, PhD, J.B. Galloway, PhD, Centre for Rheumatic Diseases, Kings College London, London, UK.
Pokaż więcej
Źródło :
The Journal of rheumatology [J Rheumatol] 2021 Aug; Vol. 48 (8), pp. 1201-1204. Date of Electronic Publication: 2021 Jun 01.
Intensive therapy for moderate established rheumatoid arthritis: the TITRATE research programme
Autorzy :
Scott DL; Centre for Rheumatic Diseases, Department of Inflammation Biology, School of Immunology and Microbial Sciences, King’s College London, London, UK Ibrahim F; Centre for Rheumatic Diseases, Department of Inflammation Biology, School of Immunology and Microbial Sciences, King’s College London, London, UK Hill H; ScHARR Health Economics and Decision Science, The University of Sheffield, Sheffield, UK Tom B; MRC Biostatistics Unit, University of Cambridge, Cambridge, UK Prothero L; Centre for Rheumatic Diseases, Department of Inflammation Biology, School of Immunology and Microbial Sciences, King’s College London, London, UK Baggott RR; Centre for Rheumatic Diseases, Department of Inflammation Biology, School of Immunology and Microbial Sciences, King’s College London, London, UK Bosworth A; National Rheumatoid Arthritis Society, Maidenhead, UK GallowayJB; Centre for Rheumatic Diseases, Department of Inflammation Biology, School of Immunology and Microbial Sciences, King’s College London, London, UK Georgopoulou S; Centre for Rheumatic Diseases, Department of Inflammation Biology, School of Immunology and Microbial Sciences, King’s College London, London, UK Martin N; Centre for Rheumatic Diseases, Department of Inflammation Biology, School of Immunology and Microbial Sciences, King’s College London, London, UK Neatrour I; Centre for Rheumatic Diseases, Department of Inflammation Biology, School of Immunology and Microbial Sciences, King’s College London, London, UK Nikiphorou E; Centre for Rheumatic Diseases, Department of Inflammation Biology, School of Immunology and Microbial Sciences, King’s College London, London, UK Sturt J; Department of Adult Nursing, Florence Nightingale Faculty of Nursing, Midwifery & Palliative Care, King’s College London, London, UK Wailoo A; ScHARR Health Economics and Decision Science, The University of Sheffield, Sheffield, UK Williams FMK; Twin Research and Genetic Epidemiology, School of Life Course Sciences, King’s College London, St Thomas’ Hospital, London, UK Williams R; Centre for Rheumatic Diseases, Department of Inflammation Biology, School of Immunology and Microbial Sciences, King’s College London, London, UK Lempp H; Centre for Rheumatic Diseases, Department of Inflammation Biology, School of Immunology and Microbial Sciences, King’s College London, London, UK
Risk-mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient survey.
Recurrent acute pericarditis diagnosed by extra-cellular volume maps.
Autorzy :
McDonaugh B; King's College Hospital NHS Foundation Trust, Denmark Hill, London SE5 9RS, UK. Perepelova N; King's College Hospital NHS Foundation Trust, Denmark Hill, London SE5 9RS, UK. Kellman P; National Institutes of Health, National Heart, Lung and Blood Institute, 31 Center Dr, Bethesda, MD 20892, USA. GallowayJB; Centre for Rheumatic Disease, King's College London, Denmark Hill, London SE5 9RS, UK. Rosmini S; King's College Hospital NHS Foundation Trust, Denmark Hill, London SE5 9RS, UK.
Pokaż więcej
Źródło :
European heart journal [Eur Heart J] 2021 Jun 13. Date of Electronic Publication: 2021 Jun 13.
A Kawasaki-like illness in an adult with recent SARS-CoV-2 infection.
Autorzy :
Nagra D; Centre for Rheumatic Disease, King's College London. Russell MD; Centre for Rheumatic Disease, King's College London. Rosmini S; King's College Hospital NHS Foundation Trust, London, UK. Sado D; King's College Hospital NHS Foundation Trust, London, UK. Buazon A; Centre for Rheumatic Disease, King's College London. Shafi T; King's College Hospital NHS Foundation Trust, London, UK. Hamlyn E; King's College Hospital NHS Foundation Trust, London, UK. Sandhu G; King's College Hospital NHS Foundation Trust, London, UK. Rutherford AI; King's College Hospital NHS Foundation Trust, London, UK. GallowayJB; Centre for Rheumatic Disease, King's College London.
Pokaż więcej
Źródło :
Rheumatology advances in practice [Rheumatol Adv Pract] 2021 May 18; Vol. 5 (2), pp. rkab035. Date of Electronic Publication: 2021 May 18 (Print Publication: 2021).
Russell MD; Centre for Rheumatic Diseases, King's College London, London. Bukhari M; Rheumatology Department, University Hospitals of Morecambe Bay NHS Foundation Trust, Lancaster. Shah AM; King's College London British Heart Foundation Centre of Excellence, King's College London, London, UK. GallowayJB; Centre for Rheumatic Diseases, King's College London, London.
Diagnostic delay is common for patients with axial spondyloarthritis: results from the National Early Inflammatory Arthritis Audit.
Autorzy :
Russell MD; Centre for Rheumatic Diseases, King's College London, London, UK. Coath F; Rheumatology Department, Norfolk and Norwich University Hospital, Norwich, UK. Yates M; Centre for Rheumatic Diseases, King's College London, London, UK. Bechman K; Centre for Rheumatic Diseases, King's College London, London, UK. Norton S; Centre for Rheumatic Diseases, King's College London, London, UK. GallowayJB; Centre for Rheumatic Diseases, King's College London, London, UK. Ledingham J; Rheumatology Department, Portsmouth Hospitals University NHS Trust, Portsmouth, UK. Sengupta R; Department of Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath, UK. Gaffney K; Rheumatology Department, Norfolk and Norwich University Hospital, Norwich, UK.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
W koszyku znajdują się zamówienia
W koszyku znajdują się zamówienia do wysłania. Czy chcesz wysłać je do realizacji?
